MedPath

effect of two drug (clonidine vs midazolam-fantanyl) in anesthesia for varicose vein surgery and relation with COMT gene

Phase 3
Conditions
Health Condition 1: I838- Varicose veins of lower extremities with other complications
Registration Number
CTRI/2021/02/030955
Lead Sponsor
Dr Rajni Gupta
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

AGE BETWEEN 18YEARS TO 60 YEARS

ASA GRADE 1 & 2

DIAGNOSED CASE OF VARICOSE VEIN

PATIENT GIVING WRITTEN INFORMED CONSENT WILL BE TAKE

Exclusion Criteria

PATIENT REFUSAL

PATIENT UNDERGONE GENERAL ANAESTHESIA WITH IN 7 DAYS, HAD TAKEN ALPHA-2 AGONIST WITH IN 14 DAYS

HEART BLOCK

PSYCHIATRIC DISORDER

ASA 3 & 4

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the sedative and analgesic effect of clonidine vs midazolam-fentanyl in Monitored Anesthesia Care (MAC) during varicose vein surgery.Timepoint: 1 year
Secondary Outcome Measures
NameTimeMethod
Effects of the COMT gene on modulating pain and its association. <br/ ><br>To assess the intra operative hemodynamic stability. <br/ ><br>To assess the post-operative safety and efficacy . <br/ ><br>Timepoint: 1 year
© Copyright 2025. All Rights Reserved by MedPath